Tilray Exports Medical Cannabis Genetics To The European Union

Europe is going green

PORTUGAL: Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal. The announcement is the first time a company has legally exported live cannabis genetics from North America Read the full article…

Tilray Receives License to Produce Medical Cannabis In The European Union

Tilray to build European Union Campus in Portugal

Company Announces €20 Million Investment to Build EU Campus and Begin Operations this Year PORTUGAL: Tilray has announced plans today to invest up to €20 million in a European Union Campus after receiving licenses from the Government of Portugal to import cannabis genetics and to cultivate cannabis for medical purposes. “Tilray’s EU Campus is another strategic Read the full article…

Tilray Announces Medical Cannabis Export To Cyprus

Tilray to export mmj to Cyprus

CANADA:  Tilray, a global leader in medical cannabis research and production, today announced that Tilray cannabinoid products have arrived and are cleared for distribution in European Union member state Cyprus after the company received necessary approvals in Canada and Cyprus to export cannabinoid formulations for patients in Cyprus. “We are proud to be able to offer Read the full article…